Baylor Scott & White The Heart Hospital, Plano, Texas, changed its treatment paradigm for its COVID-19 patients receiving ECMO during the pandemic, finding that progressive mobility and a more aggressive application of rehabilitation therapies contributed to significantly higher survival rates.
Article title: CD14-positive extracellular vesicles in bronchoalveolar lavage fluid as a new biomarker of acute respiratory distress syndrome Authors: Rahul Y. Mahida, Joshua Price, Sebastian T. Lugg, Hui Li, Dhruv Parekh, Aaron Scott, Paul Harrison, Michael A. Matthay, David R.…
A joint effort between the American Association of Critical-Care Nurses and projects funded by the U.S. Agency for International Development has made AACN’s free “COVID-19 Pulmonary, ARDS and Ventilator Resources” online course available in Spanish.
Un esfuerzo conjunto entre la Asociación Americana de Enfermeras de Cuidados Críticos (AACN) y los proyectos financiados por la Agencia de los Estados Unidos para el Desarrollo Internacional (USAID) ha hecho posible que el curso en línea gratuito de la AACN “Recursos sobre COVID-19, SDRA y Ventilación” esté disponible en español.
The growing use of mechanical circulatory support may contribute to high levels of moral distress for clinicians who regularly care for ICU patients receiving the aggressive but life-sustaining therapy, according to a study by researchers at Columbia University Irving Medical Center.
Pregnant women hospitalized with COVID-19 had improved recovery outcomes after delivering their babies early, according to new research from The University of Texas Health Science Center at Houston (UTHealth).
A designated proning team — composed of about 70 OR nurses, OR assistants and outpatient physical therapists — became a key part of the COVID-19 care provided by Massachusetts General Hospital, responding around-the-clock to patients who needed turning and allowing critical care clinicians to focus on other aspects of care.
The ATS Research Program is pleased to announce that William Zhang, MD, of Weill Cornell Medical Center is the recipient of the 2020-2021 ATS/CSL Behring Research Award in Acute Respiratory Distress Syndrome. The $50,000 award will support Dr. Zhang’s research study, “Hyperferritinemia in COVID-19 ARDS: Friend or Foe?”
A new treatment is among the first known to reduce the severity of acute respiratory distress syndrome caused by the flu in animals, according to a new study.
ROCKVILLE, MD – A tenth of all intensive care unit patients worldwide, and many critical patients with COVID-19, have acute respiratory distress syndrome (ARDS).
COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.
Researchers evaluating whether an investigational oral drug, vadadustat, can help prevent acute respiratory distress syndrome (ARDS) in COVID-19 patients were awarded $5.1 million in funding from the U.S. Department of Defense (DOD) to expand the Phase II clinical trial at UTHealth.
By the time first responders rushed the patient to Red Duke Trauma Institute at Memorial Hermann-TMC, life was already slipping away through a stab wound in the neck. The goal of the team: resuscitate and transfer the patient to the operating room, where Laura J. Moore, MD, with UTHealth, would reconstruct his severed blood vessels.
Researchers have created an experimental device that, instead of inhibiting inflammatory proteins in COVID-19 patients, changes the phenotype of circulating white blood cells, helping wean two patients off ECMO.
Researchers from the Morgridge Institute for Research, the University of Wisconsin-Madison, and Albany Medical College have identified more than 200 molecular features that strongly correlate with COVID-19 severity, offering insight into potential treatment options for those with advanced disease.
A new study published online in the Annals of the American Thoracic Society examines ways to increase the use of prone positioning for patients with severe acute respiratory distress syndrome (ARDS), and develops specific implementation strategies that can assist in clinicians’ response to the COVID-19 pandemic. Prone positioning has been shown to reduce mortality related to severe ARDS, yet most patients with ARDS—up to 85 percent—do not receive this lifesaving therapy.
New micro-credential for nurses and other healthcare professionals who provide direct care for critically ill patients with COVID-19 is among the first for clinical care. AACN is the first professional nursing organization to offer a micro-credential.
Researchers at Children’s Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania have identified a cellular pathway that can be targeted with a naturally occurring drug to stimulate lung tissue regeneration, which is necessary for recovery from multiple lung injuries. The findings, which were published today in Nature Cell Biology, could lead to better therapies for patients with lung disease, including acute respiratory distress syndrome (ARDS) due to COVID-19.
Sticky webs of DNA released from immune cells known as neutrophils may cause much of the tissue damage associated with severe COVID-19 infections, according to two new studies published September 14 in the Journal of Experimental Medicine (JEM). The research, conducted by independent groups in Belgium and Brazil, suggests that blocking the release of these DNA webs could be a new therapeutic target for the management of severe forms of COVID-19.
The ATS Research Program is pleased to announce the new ATS/CSL Behring Research Award in Acute Respiratory Distress Syndrome or ARDS. The award will provide $50,000 in funding for one year.
Researchers in France have discovered that patients suffering from severe COVID-19 show changes in a class of immune cells known as unconventional T cells. The study, published today in the Journal of Experimental Medicine (JEM), suggests that monitoring the activity of these cells in the blood of patients could predict the severity and course of the disease.
Physicians are studying whether vadadustat, an investigational therapy, could protect the lungs of COVID-19 patients by triggering the body’s protective response to low oxygen levels in a randomized Phase II clinical trial at UTHealth.
Vanderbilt University Medical Center designed and rapidly deployed a curriculum specifically to equip nurses new to ECMO with the knowledge, skills and confidence necessary to provide proficient and safe care for patients receiving ECMO. The pre-COVID ECMO training proved to be an effective, resource-efficient and pragmatic solution that can be used across different types of ICUs and across institutions.
A new Viewpoint article published online in the Annals of the American Thoracic Society examines ventilation and medication strategies that can help avoid psychological trauma for severe COVID-19 survivors treated for acute respiratory distress syndrome (ARDS) with mechanical ventilation.
A new paper published online in the Annals of the American Thoracic Society examines ventilation and medication strategies that can help avoid psychological trauma for severe COVID-19 survivors treated for acute respiratory distress syndrome (ARDS) with mechanical ventilation.
In a new paper published online in the Annals of the American Thoracic Society, researchers have been unable to produce two theorized subphenotypes of COVID-19 related acute respiratory distress syndrome (ARDS). Scientists previously proposed that two phenotypes exist that differentiate patients with more severe COVID-19 and indicate that they should be treated differently. A phenotype is a set of characteristics used to classify a patient, which may influence disease management.
The University of Illinois at Chicago is enrolling patients in a second clinical trial to study the drug remdesivir as a treatment for COVID-19. Funded by the National Institute of Allergy and Infectious Disease (NIAID), this international randomized, placebo-controlled clinical trial will…
An interprofessional simulation-based educational program helped Mount Sinai Hospital train nearly 90% of its medical ICU staff to care for patients in prone position, as part of its 2018 implementation of a new protocol related to prone position ventilation for patients with acute respiratory distress syndrome.
The first COVID-19 patient in Texas has been enrolled in a stem cell therapy clinical trial for acute respiratory distress syndrome (ARDS) at The University of Texas Health Science Center at Houston (UTHealth).
The American Association of Critical-Care Nurses has created an online course that specifically addresses the most serious reported symptoms from COVID-19. The course is available to all nurses, at no charge, to provide vital resources during this challenging time.